APA

Billing H., Höcker B., Fichtner A., van Damme-Lombaerts R., Friman S., Jaray J., Vondrak K., Sarvary E., Dello Strologo L., Oellerich M., von Ahsen N. & Tönshoff B. (20171128). Single-Nucleotide Polymorphism of CYP3A5 Impacts the Exposure to Tacrolimus in Pediatric Renal Transplant Recipients: A Pharmacogenetic Substudy of the TWIST Trial. : Therapeutic drug monitoring.

Chicago

Billing Heiko, Höcker Britta, Fichtner Alexander, van Damme-Lombaerts Rita, Friman Styrbjorn, Jaray Jenö, Vondrak Karel, Sarvary Eniko, Dello Strologo Luca, Oellerich Michael, von Ahsen Nicolas and Tönshoff Burkhard. 20171128. Single-Nucleotide Polymorphism of CYP3A5 Impacts the Exposure to Tacrolimus in Pediatric Renal Transplant Recipients: A Pharmacogenetic Substudy of the TWIST Trial. : Therapeutic drug monitoring.

Harvard

Billing H., Höcker B., Fichtner A., van Damme-Lombaerts R., Friman S., Jaray J., Vondrak K., Sarvary E., Dello Strologo L., Oellerich M., von Ahsen N. and Tönshoff B. (20171128). Single-Nucleotide Polymorphism of CYP3A5 Impacts the Exposure to Tacrolimus in Pediatric Renal Transplant Recipients: A Pharmacogenetic Substudy of the TWIST Trial. : Therapeutic drug monitoring.

MLA

Billing Heiko, Höcker Britta, Fichtner Alexander, van Damme-Lombaerts Rita, Friman Styrbjorn, Jaray Jenö, Vondrak Karel, Sarvary Eniko, Dello Strologo Luca, Oellerich Michael, von Ahsen Nicolas and Tönshoff Burkhard. Single-Nucleotide Polymorphism of CYP3A5 Impacts the Exposure to Tacrolimus in Pediatric Renal Transplant Recipients: A Pharmacogenetic Substudy of the TWIST Trial. : Therapeutic drug monitoring. 20171128.